Skip to main content
. 2022 Aug 3;2022(8):CD013829. doi: 10.1002/14651858.CD013829.pub2

1.5. Analysis.

1.5

Comparison 1: Primary outcome: lung cancer‐related mortality, Outcome 5: Lung cancer‐related mortality – by time postscreening cessation (including unplanned time points)